Oxford and Cambridge unite against covid-19 in India
Image credit: Creative Commons
Societies from Oxford and Cambridge have launched a joint fundraiser towards COVID-19 relief in India, which is currently beset by a chaotic coronavirus situation. The Oxford India Society, Oxford Hindu Society, and Oxford South Asian Society’s original fundraiser reached its target of £10,000 less than 72 hours after launching, much faster than the expected timeline of 10 days.
Following their success, they teamed up with the Cambridge University India Society, Cambridge South Asian Forum, and the Cambridge University Bharatiya Society to collectively launch an even bigger fundraiser which is aiming to raise £50,000 in 10 days.
Family members of COVID patient complain about shortage of hospital beds in Lucknow
SECTIONS
Last Updated: Apr 17, 2021, 02:04 PM IST
Share
Synopsis My grandmother cannot be admitted as there is no bed in any hospital in Lucknow. Despite calling the helpline number, there is no concrete response. The oxygen level, which was 66, has now dropped to near 40. It is an alarming sign, the grandson of the woman said.
PTI
A shortage of hospital beds in Lucknow seems to have kept a 65-year-old COVID-19 patient waiting for proper treatment.
The family members of the woman claimed that she could not be admitted to a hospital as no beds were available in the capital city of Uttar Pradesh.
Lucknow: COVID-19 patient s family complains about shortage of hospital beds newsbytesapp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsbytesapp.com Daily Mail and Mail on Sunday newspapers.
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.
Cipla s Gulf arm to market, sell 4 biosimilar medicines in NZ, Australia
Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing
PTI | March 3, 2021 | Updated 07:47 IST
Drug major Cipla on Tuesday said its Gulf subsidiary is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing.